United Therapeutics (UTHR) Tops Q4 EPS by 60c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $536.59 -2.7%
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $7.70, $0.60 better than the analyst estimate of $7.10. Revenue for the quarter came in at $790.2 million versus the consensus estimate of $815.24 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Blue Star Gold closes final tranche of flow-through private placement
- SanDisk and Micron surge as Apple confirms memory price pass-through
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
